Altitude sickness mechanisms
As altitude increases, partial pressure of oxygen (pO₂) falls proportionally:
- At 3,500 m: pO₂ = 65% of sea level
- At 5,000 m: pO₂ = 53% of sea level
- At 8,000 m: pO₂ = 37% of sea level
The physiological responses:
- Immediate (0–24h):Hyperventilation (reduces CO₂, raises blood pH — respiratory alkalosis). Heart rate increases. Blood viscosity initially increases from haemoconcentration (dehydration from breathing cold dry air).
- Short-term (1–7 days):Kidneys excrete bicarbonate to compensate respiratory alkalosis. EPO secretion from renal peritubular cells increases — stimulating red blood cell production over days to weeks.
- AMS mechanism:Hypoxic vasodilation in the brain increases cerebral blood flow; hypoxia-induced oxidative stress (NADPH oxidase activation in endothelial cells) damages the blood-brain barrier, leading to vasogenic oedema. IL-6 and TNF-α are elevated in AMS.
Phycocyanobilin and hypoxic oxidative stress
At altitude, NADPH oxidase (NOX2 and NOX4) is activated in vascular endothelial cells by hypoxia-inducible factor 1α (HIF-1α) — generating superoxide that depletes nitric oxide (NO) and damages the blood-brain barrier.
Phycocyanobilin specifically inhibits NADPH oxidase, addressing the primary ROS source in hypoxic endothelial cells. This differs from standard antioxidants (vitamin C, E, NAC) which scavenge ROS after production — phycocyanobilin prevents production at the source.
Critical distinction: NADPH oxidase inhibition does not impair the HIF-1α signalling needed for altitude adaptation (EPO upregulation, VEGF-driven angiogenesis). HIF-1α stability is regulated by prolyl hydroxylases and pO₂, not NADPH oxidase — so spirulina doesn’t blunt the adaptation response.
Iron and EPO response at altitude
EPO secretion at altitude drives the production of new red blood cells — the primary long-term acclimatisation mechanism. But EPO-driven erythropoiesis requires iron for haemoglobin synthesis:
- Each new red blood cell requires approximately 0.4 mg haem iron
- At altitude, RBC production can increase by 20–30% above baseline — requiring a significant iron reservoir
- Athletes and trekkers with low ferritin (<50 µg/L) may have a blunted EPO response even with elevated EPO — because iron is the rate-limiting substrate for haemoglobin synthesis
Pre-altitude iron loading protocol (recommended in sports medicine for altitude training camps):
- Test ferritin 6–8 weeks before altitude travel
- Target ferritin above 50 µg/L before ascent (preferably 70–80 µg/L for extended time at altitude)
- Spirulina 5–10 g/day with vitamin C from 8 weeks pre-altitude is appropriate for maintenance/borderline ferritin (30–70 µg/L)
- Ferritin below 30 µg/L: add therapeutic iron (ferrous bisglycinate 25–50 mg elemental iron) alongside spirulina
Acetazolamide and spirulina
Acetazolamide (Diamox) is the primary pharmacological prevention for AMS — it accelerates bicarbonate excretion, preventing the alkalosis that slows the ventilatory response to hypoxia.
- No pharmacokinetic interaction between acetazolamide and spirulina
- Acetazolamide causes bicarbonate diuresis — compatible with spirulina’s unrelated mechanisms
- Spirulina is complementary to, not a replacement for, acetazolamide for AMS prevention in rapid-ascent scenarios
Practical protocol for altitude preparation
- 6–8 weeks before altitude:Test ferritin. Start 5–10 g spirulina daily with vitamin C. Add therapeutic iron if ferritin is below 30 µg/L.
- At altitude:Continue spirulina for phycocyanobilin oxidative stress protection. Maintain hydration — altitude dry air causes significant dehydration that worsens blood viscosity.
- Ascent rate:Above 3,000 m, limit ascent to 300–500 m/day of sleeping altitude. No supplement replaces appropriate acclimatisation pace — this is the primary AMS prevention strategy.
- If AMS symptoms develop (headache, nausea, fatigue, dizziness):Stop ascending. Descend if symptoms worsen. Spirulina is not a treatment for AMS — seek descent and medical attention for moderate-to-severe symptoms.